The potent oxidant anticancer activity of organoiridium catalysts.
about
Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands.Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design.Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor CellsEster-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.Organoiridium complexes: anticancer agents and catalystsBringing inorganic chemistry to life with inspiration from R. J. P. Williams.Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.Innocent But Deadly: Nontoxic Organoiridium Catalysts Promote Selective Cancer Cell Death.A survey of the mechanisms of action of anticancer transition metal complexes.Organometallic rhodium(III) and iridium(III) cyclopentadienyl complexes with curcumin and bisdemethoxycurcumin co-ligands.Redox-active and DNA-binding coordination complexes of clotrimazole.Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity.Theranostic iridium(III) complexes as one- and two-photon phosphorescent trackers to monitor autophagic lysosomes.Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy.A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex.The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.Riboflavin as a bioorthogonal photocatalyst for the activation of a PtIV prodrug.Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands.Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action.Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.Half-sandwich iridium N-heterocyclic carbene anticancer complexes.Designing new iridium(iii) arene complexes of naphthoquinone derivatives as anticancer agents: a structure-activity relationship study.Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.Functionalized Ultrasmall Fluorinated Graphene with High NIR Absorbance for Controlled Delivery of Mixed Anticancer Drugs.Structure and reactivity of [RuII(terpy)(N^N)Cl]Cl complexes: consequences for biological applications.Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes.Catalytic Metallodrugs: Substrate-Selective Metal Catalysts as Therapeutics.Iridium Complexes as a Roadblock for DNA Polymerase during Amplification.Synthesis and structures of a pincer-type rhodium(iii) complex: reactivity toward biomolecules.Pseudo electron-deficient organometallics: limited reactivity towards electron-donating ligands.Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.Cyclometallated iridium complexes inducing paraptotic cell death like natural products: synthesis, structure and mechanistic aspects.Asymmetric transfer hydrogenation by synthetic catalysts in cancer cells.Somatostatin receptor-targeted organometallic iridium(iii) complexes as novel theranostic agents.Pyridylphosphinate metal complexes: synthesis, structural characterisation and biological activity.Enantiopure Ferrocene-Based Planar-Chiral Iridacycles: Stereospecific Control of Iridium-Centred Chirality.Aquation Is a Crucial Activation Step for Anticancer Action of Ruthenium(II) Polypyridyl Complexes to Trigger Cancer Cell Apoptosis.Transfer Hydrogenation and Antiproliferative Activity of Tethered Half-Sandwich Organoruthenium Catalysts.
P2860
Q34331245-A164984E-ACE0-4FFB-88EA-7244210C85E7Q35247064-0A95FD0D-3463-47FA-927D-28EEB34CE183Q36499563-97346254-FA97-4DAC-9C28-A6FD936FA6EEQ37498914-8EFBD6F8-1E5F-4A72-A600-8BB5E4F21EABQ37715044-B009CF4E-45ED-4CEB-A69F-417496F03356Q38560599-0576832A-AF81-4B33-A415-090B1E7ACC04Q38704083-04AC1817-41B0-4D14-89AD-216A3175C546Q38722983-68727BB1-5078-486C-8DF3-1B4400BCE271Q38792102-657E53A8-D5B8-4139-B001-15169BBEB2F5Q38821097-64759383-A86D-417B-8440-73D0E7E9F06BQ38922941-94355AA3-4C5F-447E-9F94-296E42C33B37Q38942212-50049C86-5C17-4007-9CAF-781ED941D507Q38951818-9C68ED44-E734-4A88-BF96-EC198803EFA5Q38954296-1BD5A6B3-47E5-4B8C-89F1-F6B9240DB669Q38968516-C0FD74C7-5E5E-47D6-98FD-8E99065EF6A6Q38994934-81A44A3E-6802-4CFF-8D5F-C7B37E7CF103Q39400527-9EC95968-FDEA-4337-846F-4BE72A2E1039Q41832876-375ED206-CFD6-41DD-B79A-25B4A3762120Q42400560-68A7E2F7-9F02-453D-AC35-23204946AF9CQ46262834-C4E676C6-FCEC-4649-98BA-9AF057AAADDCQ46271057-4CE03B1E-2AC6-421A-9D2F-2CC8FBA46AC9Q46320244-990C256D-D254-4FDD-B29E-BB5EB5820748Q46384231-CFF2C7BA-0871-43C4-BAA8-DC2494D1739DQ46425575-E5CD16AC-B370-41F6-B7C2-85414362E717Q47343997-8FB27E88-A938-4B96-A5A6-7047CC797C67Q47684733-7A66E65E-1847-4F71-B597-7B36F1A7DC4AQ47959566-4DA5B07A-53F8-4BA1-8854-188D6DC07BA3Q48148699-D37E510C-12E1-417D-B21E-CB8836C6A2CCQ48157762-47C58D18-7061-4E61-8F61-35441BD6EF0BQ48218977-4BAD6FD4-0C62-40E2-A9DD-4E1BE80D3A3DQ48312077-F1E7F45E-007E-4B17-94F2-A10BCDBC4074Q50022263-5ED614A3-F973-44C7-A206-F175CF8341E0Q51347617-87C7BAE5-9C2F-4BE6-B3D8-9BEE96BCC17EQ51423158-F9E7D9D7-4A67-4C30-8CD9-42A7CAA4E5B0Q51749836-48FE6CB5-60F3-4977-B49F-B5A506C659F0Q52662227-76BF8241-EF7B-4DEA-AAA1-313EFDB12D9BQ52984993-4660B544-9080-46F6-85CA-12842FBA2188Q53174513-3C83B4DB-A0E1-4868-A5E8-7A21EB9FBDC9Q53463488-052F31C8-646B-4B72-B314-5066C459A717Q54978767-7CEC2738-4981-4894-BF56-F1E4026BD222
P2860
The potent oxidant anticancer activity of organoiridium catalysts.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The potent oxidant anticancer activity of organoiridium catalysts.
@ast
The potent oxidant anticancer activity of organoiridium catalysts.
@en
The potent oxidant anticancer activity of organoiridium catalysts.
@nl
type
label
The potent oxidant anticancer activity of organoiridium catalysts.
@ast
The potent oxidant anticancer activity of organoiridium catalysts.
@en
The potent oxidant anticancer activity of organoiridium catalysts.
@nl
prefLabel
The potent oxidant anticancer activity of organoiridium catalysts.
@ast
The potent oxidant anticancer activity of organoiridium catalysts.
@en
The potent oxidant anticancer activity of organoiridium catalysts.
@nl
P2093
P2860
P50
P356
P1476
The potent oxidant anticancer activity of organoiridium catalysts.
@en
P2093
Bushra Qamar
Guy J Clarkson
Jessica M Hearn
Nicolas P E Barry
Peter J Sadler
P2860
P304
P356
10.1002/ANIE.201311161
P407
P577
2014-03-11T00:00:00Z